Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 4
1954 1
1955 1
1956 1
1957 5
1958 4
1959 3
1961 2
1962 2
1963 2
1966 3
1969 2
1971 3
1972 1
1973 2
1974 2
1975 3
1976 1
1979 2
1981 1
1982 1
1983 3
1984 3
1985 2
1986 4
1988 6
1989 5
1991 8
1992 7
1993 5
1994 2
1995 8
1996 8
1997 6
1998 6
1999 5
2000 8
2001 4
2002 6
2003 6
2004 11
2005 5
2006 7
2007 11
2008 4
2009 11
2010 6
2011 9
2012 2
2013 4
2014 4
2015 1
2016 1
2017 2
2018 3
2019 4
2020 1
2021 6
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

236 results

Results by year

Filters applied: . Clear all
Page 1
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.
Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, Yokoi T, Chiappori A, Lee KH, de Wit M, Cho BC, Bourhaba M, Quantin X, Tokito T, Mekhail T, Planchard D, Kim YC, Karapetis CS, Hiret S, Ostoros G, Kubota K, Gray JE, Paz-Ares L, de Castro Carpeño J, Wadsworth C, Melillo G, Jiang H, Huang Y, Dennis PA, Özgüroğlu M; PACIFIC Investigators. Antonia SJ, et al. Among authors: melillo g. N Engl J Med. 2017 Nov 16;377(20):1919-1929. doi: 10.1056/NEJMoa1709937. Epub 2017 Sep 8. N Engl J Med. 2017. PMID: 28885881 Free article. Clinical Trial.
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.
Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, Kurata T, Chiappori A, Lee KH, de Wit M, Cho BC, Bourhaba M, Quantin X, Tokito T, Mekhail T, Planchard D, Kim YC, Karapetis CS, Hiret S, Ostoros G, Kubota K, Gray JE, Paz-Ares L, de Castro Carpeño J, Faivre-Finn C, Reck M, Vansteenkiste J, Spigel DR, Wadsworth C, Melillo G, Taboada M, Dennis PA, Özgüroğlu M; PACIFIC Investigators. Antonia SJ, et al. Among authors: melillo g. N Engl J Med. 2018 Dec 13;379(24):2342-2350. doi: 10.1056/NEJMoa1809697. Epub 2018 Sep 25. N Engl J Med. 2018. PMID: 30280658 Free article. Clinical Trial.
Magnetocardiographically-guided catheter ablation.
Fenici RR, Covino M, Cellerino C, Di Lillo M, De Filippo MC, Melillo G. Fenici RR, et al. Among authors: melillo g. J Interv Cardiol. 1995 Dec;8(6 Suppl):825-36. doi: 10.1111/j.1540-8183.1995.tb00936.x. J Interv Cardiol. 1995. PMID: 10159774 Review.
microRNAs involved in psoriasis and cardiovascular diseases.
Sileno S, Beji S, D'Agostino M, Carassiti A, Melillo G, Magenta A. Sileno S, et al. Among authors: melillo g. Vasc Biol. 2021 Jun 3;3(1):R49-R68. doi: 10.1530/VB-21-0007. eCollection 2021. Vasc Biol. 2021. PMID: 34291190 Free PMC article. Review.
Hypoxia: jump-starting inflammation.
Melillo G. Melillo G. Blood. 2011 Mar 3;117(9):2561-2. doi: 10.1182/blood-2010-12-324913. Blood. 2011. PMID: 21372159 Free article.
Hypoxia: a double-edged sword of immunity.
Sica A, Melillo G, Varesio L. Sica A, et al. Among authors: melillo g. J Mol Med (Berl). 2011 Jul;89(7):657-65. doi: 10.1007/s00109-011-0724-8. Epub 2011 Feb 19. J Mol Med (Berl). 2011. PMID: 21336851 Review.
Magnetocardiography: ventricular arrhythmias.
Fenici R, Melillo G. Fenici R, et al. Among authors: melillo g. Eur Heart J. 1993 Sep;14 Suppl E:53-60. doi: 10.1093/eurheartj/14.suppl_e.53. Eur Heart J. 1993. PMID: 8223756
236 results